Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (3)
  • 2024 (3)
  • 2023 (8)
  • 2022 (10)
  • 2021 (11)
  • 2020 (2)

Subject

  • Drug Trafficking (106)
  • Prescription Drugs (77)
  • Pharmaceuticals/Pharmacists/Physicians (48)
  • OCDETF/Task Force (34)
  • Fake Pills (30)
  • Synthetic drugs (26)
  • Guns/Weapons (25)
  • Seizures (Drugs/Property) (15)
  • Overdose (14)
  • Task Forces/Task Force Officers (13)
  • Arrests/Convictions - Major (12)
  • Guilty Plea (11)
  • Major Law Enforcement Operation (7)
  • Dark Web- Internet Trafficking (6)
  • Take Back Day (5)
  • Asset Forfeiture (3)
  • Gangs (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Counterfeit Pills (2)
  • Outreach/Drug Prevention (2)
  • Press Conferences (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Congressional Affairs (1)
  • HIDTA (1)
  • Money Laundering (1)
  • Diversion Division (38)

Drug Name

  • Opioids (43)
  • Fentanyl (33)
  • Hydromorphone (16)
  • Synthetic Opioids (10)
  • Benzodiazepines (9)
  • Morphine (7)
  • Methamphetamine (6)
  • Amphetamines (4)
  • Cocaine (3)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Oxycodone (38)

Field Division

  • Washington, DC (11)
  • Atlanta (6)
  • Seattle (4)
  • Chicago (3)
  • New Jersey (3)
  • New York (3)
  • New England (2)
  • El Paso (1)
  • Houston (1)
  • Miami (1)
  • New Orleans (1)
  • Sede (1)
  • St. Louis (1)
Clear All Results
38 Results - Showing 11 to 20
PRESS RELEASE

Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths

ANCHORAGE, ALASKA—Former Advanced Nurse Practitioner Jessica Joyce Spayd (52) was sentenced in U.S. District Court yesterday to 30 years (360 months) imprisonment for illegally prescribing and dispensing opioids outside the scope of legitimate medical practice that resulted in the deaths of five people between 2014 and 2019. United States District...
PRESS RELEASE

Long Island Doctor Sentenced to 36 Months in Prison for Illegal Distribution of Oxycodone

BROOKLYN, N.Y. - Earlier today, in federal court in Central Islip, Frank Parasmo, a former medical doctor, was sentenced by United States District Judge Joan M. Azrack to 36 months in prison for his conviction on 32 counts of unlawfully distributing oxycodone, a highly addictive prescription painkiller, to 18 patients...
PRESS RELEASE

DOJ and Lincoln Pharmacy in Tacoma Settle Allegations the Pharmacy Failed to Follow the Controlled Substances Act

SEATTLE – The U.S. Attorney’s Office and Lincoln Pharmacy in Tacoma have reached a settlement agreement over inspection findings by the Drug Enforcement Administration that Lincoln had failed to comply with some of the administrative requirements of the Controlled Substances Act (CSA). Lincoln Pharmacy will pay the United States $80,000...
PRESS RELEASE

Armed Drug Trafficker with Multiple Criminal Convictions is Sentenced to 26 Years in Prison

ASHEVILLE, NC – U.S. Attorney Dena J. King announced today that Benjamin Dann Owens, 36, of Hayesville, N.C., was sentenced to 312 months in prison followed by five years of supervised release for conspiracy to distribute and to possess with intent to distribute fentanyl, methamphetamine, Oxycodone, and other narcotics as...
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...

Paginación

  • Primera página «
  • Anterior
  • Página 1
  • Current page 2
  • Página 3
  • Página 4
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster